[HTML][HTML] Enhancing the potency of chemotherapeutic agents by combination with bromelain and N-acetylcysteine-an in vitro study with pancreatic and hepatic cancer …

K Pillai, AH Mekkawy, J Akhter, S Badar… - American Journal of …, 2020 - ncbi.nlm.nih.gov
Current systemic dosages of chemotherapeutic drugs such as gemcitabine, 5-FU, cisplatin,
doxorubicin are administered every 7 days over 4 cycles due to systemic toxicity. An …

Enhancing the potency of chemotherapeutic agents by combination with bromelain and N-acetylcysteine-an in vitro study with pancreatic and hepatic cancer cells

K Pillai, AH Mekkawy, J Akhter… - American journal …, 2020 - pubmed.ncbi.nlm.nih.gov
Current systemic dosages of chemotherapeutic drugs such as gemcitabine, 5-FU, cisplatin,
doxorubicin are administered every 7 days over 4 cycles due to systemic toxicity. An …

Enhancing the potency of chemotherapeutic agents by combination with bromelain and N-acetylcysteine-an in vitro study with pancreatic and hepatic cancer cells.

K Pillai, AH Mekkawy, J Akhter, S Badar… - American Journal of …, 2020 - europepmc.org
Current systemic dosages of chemotherapeutic drugs such as gemcitabine, 5-FU, cisplatin,
doxorubicin are administered every 7 days over 4 cycles due to systemic toxicity. An …

[PDF][PDF] Enhancing the potency of chemotherapeutic agents by combination with bromelain and N-acetylcysteine-an in vitro study with pancreatic and hepatic cancer …

K Pillai, AH Mekkawy, J Akhter, S Badar, L Dong… - Am J Transl Res, 2020 - e-century.us
Current systemic dosages of chemotherapeutic drugs such as gemcitabine, 5-FU, cisplatin,
doxorubicin are administered every 7 days over 4 cycles due to systemic toxicity. An …